Editorial Board
Takafumi Yokota
Chief Director, Osaka International Cancer Institute, Osaka · Japan
Editorial leadership for Journal of Evolving Stem Cell Research ISSN 2574-4372
Research interests
- Hematopoietic Stem Cells Hematopoiesis Lymphopoiesis
Biography
- 1991-1992: Osaka University Medical School Hospital (Resident doctor).
- 1992-1994: Osaka Medical Center for Cancer and Cardiovascular Diseases (Resident doctor).
- 1994-1995: Osaka University Medical School Hospital.
- 1995-2000: Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.
- 2000-2003: Associate Research Scientist, Immunobiology and Cancer Program, Oklahoma Medical Research Foundation.
- 2003-2004: Senior Research Scientist, Immunobiology and Cancer Program, Oklahoma Medical Research Foundation.
- 2004-2008: Research Scientist, Department of Hematology and Oncology, Osaka University Graduate School of Medicine.
- 2008-present: Assistant Professor, Department of Hematology and Oncology, Osaka University Graduate School of Medicine.
Selected publications
- Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome 2024 cited 58×
- Group 2 innate lymphoid cells support hematopoietic recovery under stress conditions 2021 cited 50×
- Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis 2018 cited 21×
- Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors 2022 cited 6×
- Inotuzumab ozogamicin and blinatumomab sequential therapy for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia 2022 cited 2×
- A newly identified gene Ahed plays essential roles in murine haematopoiesis 2024 cited 1×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JESR for your work?
This journal is guided by Takafumi Yokota (Chief Director, Osaka International Cancer Institute, Osaka) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.